RENBP and cancer: To be precise, the administration of AGE-RAGE inhibitors in combination with chemotherapy can be decided based on the individual patient profile identifying the pathological stage of cancer and immuno-histochemical/biochemical studies identifying the person-specific expression of AGEs, RAGE and sRAGE.